Published-Ahead-of-Print October 16, 2008, DOI:10.2164/jandrol.108.005785
Journal of Andrology, Vol. 30, No. 2, March/April 2009
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.108.005785
Homo sapiens Lactate Dehydrogenase c (Ldhc) Gene Expression in Cancer Cells Is Regulated by Transcription Factor Sp1, CREB, and CpG Island Methylation
HUANGHUI TANG AND
ERWIN GOLDBERG
From the Department of Biochemistry, Molecular Biology, and Cell Biology,
Northwestern University, Evanston, Illinois.
|
Correspondence to: Dr HuangHui Tang, Department of Biochemistry, Molecular
Biology and Cell Biology, Northwestern University, Evanston, IL 60208 (e-mail:
h-tang2{at}northwestern.edu). |
The human testis-specific lactate dehydrogenase c gene (hLdhc) is
transcribed only in cells of the germinal epithelium. Recently hLdhc
was reported to express in a broad spectrum of tumors with relatively high
frequency in lung cancer, melanoma, and breast cancer, and in some prostate
cancers. Two melanoma cell lines that express the hLdhc gene, A375M
and C81-61, were identified and were used to characterize the hLdhc
promoter and explore transcriptional regulation of this gene. A 110-bp core
promoter, including a conserved GC box and cyclic adenosine
monophosphate–responsive element (CRE), were identified as essential for
basal promoter activity. The methylation status of the CpG island (CGI) in the
hLdhc core promoter sequence was analyzed in
hLdhc-expressing and nonexpressing cells and human prostate tumor
tissues. The CGI in 2 cell lines expressing the gene was hypomethylated
whereas the DNA from cells that did not express hLdhc was
hypermethylated. The role of methylation in regulating this promoter was
confirmed by experimental induction of hLdhc transcription with the
methylation inhibitor 5'aza-deoxycytidine. Quantitative analyses of the
methylation level in the CGI were performed in prostate tumor tissues by
pyrosequencing. Overall, these experiments demonstrated that hLdhc
expression in cancer cells was regulated by transcription factor Sp1 and CREB
and promoter CGI methylation. In addition, these findings suggest the
possibility of developing a biomarker for cancer diagnosis/prognosis based on
DNA methylation of the Ldhc gene.
Key words: DNA methylation, cancer/testis antigen, promoter
Copyright © 2009 by The American Society of Andrology.